Cetera Investment Advisers’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,001
Closed -$231K 4925
2025
Q4
$231K Sell
9,001
-5,272
-37% -$121K ﹤0.01% 4134
2025
Q3
$307K Sell
14,273
-30,849
-68% -$701K ﹤0.01% 3814
2025
Q2
$993K Buy
45,122
+2,809
+7% +$61.6K ﹤0.01% 2378
2025
Q1
$945K Buy
+42,313
New +$911K ﹤0.01% 2305
2024
Q3
Sell
-21,460
Closed -$614K 3869
2024
Q2
$614K Buy
21,460
+5,216
+32% +$157K ﹤0.01% 2437
2024
Q1
$620K Buy
16,244
+8,812
+119% +$333K ﹤0.01% 2442
2023
Q4
$276K Buy
7,432
+1,154
+18% +$38.7K ﹤0.01% 1832
2023
Q3
$214K Buy
6,278
+978
+18% +$36.9K ﹤0.01% 1948
2023
Q2
$209K Buy
+5,300
New +$191K ﹤0.01% 1962
2022
Q2
Sell
-6,581
Closed -$338K 1921
2022
Q1
$338K Buy
6,581
+222
+3% +$9.51K ﹤0.01% 1409
2021
Q4
$320K Buy
6,359
+270
+4% +$15.1K ﹤0.01% 1458
2021
Q3
$341K Buy
6,089
+997
+20% +$55.1K 0.01% 1355
2021
Q2
$300K Buy
+5,092
New +$286K ﹤0.01% 1420

Other funds holding PGNY

Cetera Investment Advisers's PGNY Position: Q1 2026 in Review

Cetera Investment Advisers sold out of Progyny (PGNY) in Q1 2026, closing a stake of 9,001 shares — an estimated $231K sold.

Cetera Investment Advisers first reported a position in PGNY in Q2 2021 and held it in 13 quarters. The position peaked at $993K in Q2 2025. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Cetera Investment Advisers reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 9,001 Progyny shares in Q1 2026, an estimated $231K.
  • Cetera Investment Advisers first reported a position in Progyny in Q2 2021 and held it in 13 quarters.
  • Cetera Investment Advisers's Progyny position peaked at $993K in Q2 2025.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.